Conventional treatments for psoriasis, a common and debilitating skin condition, have been limited either because of extreme toxicity or extreme inconvenience.But new hope has been placed in “targeted biologic therapies,” and two of these receive a big boost from studies appearing in the Nov. 20 issue of the New England Journal of Medicine.
